Literature DB >> 12706952

Difficult-to-treat depression: the role of contexts and comorbidities.

Nancy K Grote1, Ellen Frank.   

Abstract

In this review, we examine several special psychosocial contexts, including pregnancy and motherhood, that may seriously interfere with depressed patients' ability or willingness to engage and remain in treatment for their depression. We also explore the kinds of often-unrecognized subsyndromal comorbidities, such as panic-agoraphobic spectrum, that may complicate conventional treatments for depression or prevent depressed patients from remaining engaged long enough to fully benefit from treatment. We argue that psychotherapy can play a crucial role in addressing the special psychosocial contexts and the kinds of comorbidities experienced by the patient with difficult-to-treat depression. For difficult-to-treat depression during pregnancy and motherhood, preliminary data from several studies suggest that 8-24 sessions of weekly interpersonal psychotherapy (IPT), often followed by monthly maintenance IPT, is a promising long-term treatment for both middle- and low-income women. For difficult-to-treat depression with panic-agoraphobic subsyndromal features, preliminary results suggest that an integrated treatment approach, combining IPT for depression and cognitive-behavioral treatment for coexisting symptoms of panic, leads to higher depression response rates. These data imply that tailoring treatments to patients' specific needs and circumstances may be the real key to making depression less difficult to treat. Copyright 2003 Society of Biological Psychiatry

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706952     DOI: 10.1016/s0006-3223(03)00006-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

2.  The 5-year longitudinal diagnostic profile and health services utilization of patients treated with electroconvulsive therapy in Quebec: a population-based study.

Authors:  Simon Lafrenière; Fatemeh Gholi-Zadeh-Kharrat; Caroline Sirois; Victoria Massamba; Louis Rochette; Camille Brousseau-Paradis; Simon Patry; Christian Gagné; Morgane Lemasson; Geneviève Gariépy; Chantal Mérette; Elham Rahme; Alain Lesage
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-09-26       Impact factor: 4.519

3.  Randomized trial of promoting first relationships for new mothers who received community mental health services in pregnancy.

Authors:  Monica L Oxford; Jonika B Hash; Mary J Lohr; Maria E Bleil; Charlie B Fleming; Jurgen Unützer; Susan J Spieker
Journal:  Dev Psychol       Date:  2021-08

Review 4.  Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.

Authors:  Kristina M Deligiannidis; Nancy Byatt; Marlene P Freeman
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

5.  Culturally relevant treatment services for perinatal depression in socio-economically disadvantaged women: the design of the MOMCare study.

Authors:  Nancy K Grote; Wayne J Katon; Mary Jane Lohr; Kathy Carson; Mary Curran; Erin Galvin; Joan E Russo; Marilyn Gregory
Journal:  Contemp Clin Trials       Date:  2014-07-10       Impact factor: 2.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.